Latest hyperkalemia Stories
Saint Luke’s Mid America Heart Institute cardiologist presents findings at American Heart Association Scientific Meeting, results simultaneously published in JAMA Kansas
WOODCLIFF LAKE, N.J., April 7, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S.
In addition to experiencing negative health effects from their disease, patients with chronic kidney disease (CKD) are also at risk of experiencing hazardous events potentially related to medical treatments they receive.
d’Oliveira & Associates has issued a new infographic providing information on a Tekturna medical study that was stopped due to patients suffering from nonfatal stroke, hyperkalemia, and
Box jellyfish are known to lurk in the waters off the coast of Hawaii and a pair of researchers from the island state have found a treatment that takes some of the sting out of the invertebrate’s deadly venom.
Dangerous Side Effects Linked to Blood Pressure Medication TEKTURNA (PRWEB) December 08, 2012
A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice.
Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.
Patients hospitalized after a heart attack who had blood potassium levels of between 3.5 and less than 4.5 mEq/L (milliEquivalents per liter) had a lower risk of death than patients with potassium levels that were higher or lower than this range.
Roughly 5 million people in the United States live with heart failure, a condition in which the heart is unable to pump blood around the body effectively.